计算溶液所需的质量、体积或浓度。
Polatuzumab (anti-CD79b) (Ab175715) - ELISA
Immobilized hu-CD79b-His at 2 μg/mL can bind Polatuzumab (anti-CD79b) (Ab175715) with the EC₅₀ of 4.09 ng/mL.
ExactAb™,已验证,无动物源,无叠氮钠,无载体,重组 级 提供 ≥95%(SDS-PAGE&SEC-HPLC) 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
-80℃储存,避免反复冻融。特低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
Polatuzumab (anti-CD79b)是一种带有化疗活性分子的单克隆抗体。Polatuzumab (anti-CD79b)靶向CD79b,CD79b存在于B细胞表面。Polatuzumab (anti-CD79b)粘附在CD79b蛋白上并将化疗活性分子输送到细胞中。然后活性分子杀死细胞。Polatuzumab (anti-CD79b)可用于合成Polatuzumab Vedotin。Polatuzumab Vedotin是CD79b的抗体活性分子偶联物(ADC)。
Polatuzumab (anti-CD79b) is a monoclonal antibody, which targets CD79b that is found on the surface of B cells. Polatuzumab (anti-CD79b) sticks to the CD79b protein and delivers the chemotherapy compound into the cell. Polatuzumab (anti-CD79b) can be used to synthesize Polatuzumab Vedotin, which is an antibody-drug conjugate (ADC) targeting CD79b.
Purity>95% (SDS-PAGE&SEC)
Endotoxin Level< 0.01EU/μg
Polatuzumab (anti-CD79b) (Ab175715) - ELISA
Immobilized hu-CD79b-His at 2 μg/mL can bind Polatuzumab (anti-CD79b) (Ab175715) with the EC₅₀ of 4.09 ng/mL.
Polatuzumab (anti-CD79b) (Ab175715) - SEC
The purity of Polatuzumab (anti-CD79b) (Ab175715) is more than 95% verified by HPLC.
Recombinant Human CD79B Protein (rp176729) - ELISA
Immobilized Recombinant Human CD79B Protein (rp176729) at 1.0 μg/mL can bind Polatuzumab (anti-CD79b) (Ab175715) with the EC50 of 11.08 ng/mL.
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | Ab175715 | |
| 分析证书 | Ab175715 | |
| 分析证书 | Ab175715 |
我们的级别选择指南涵盖了目录中所有的变体的纯度、稳定剂状态和应用适用性。
查看 Animal Free 级别指南 → 查看 Carrier Free 级别指南 → 查看 Recombinant 级别指南 → 查看 Validated 级别指南 → 查看 ExactAb™ 级别指南 → 查看 Azide Free 级别指南 →